20:03 , Feb 11, 2019 |  BC Extra  |  Company News

Agios' Schenkein joins GV

Less than two weeks after stepping down as CEO of Agios Pharmaceuticals Inc. (NASDAQ:AGIO), David Schenkein has joined GV as general partner. Schenkein, who will remain executive chairman of Agios, will co-lead the firm’s life...
03:38 , Jan 11, 2019 |  BC Innovations  |  Product R&D

PureTech turns inward

After a 15-year run of spinning out technologies into affiliate companies, PureTech Health plc is stepping away from that model in favor of an internal pipeline to advance its new platforms. Behind the structural shift...
14:54 , Sep 11, 2018 |  BC Extra  |  Company News

Management tracks: Cheng joins Akero, bluebird COO leaving

Metabolic company Akero Therapeutics Inc. (Cambridge, Mass.) named former Gilead Sciences Inc. (NASDAQ:GILD) executive Andrew Cheng president and CEO. Cheng joined Gilead in 1999 to lead its development programs in HIV/AIDS and became an EVP...
19:35 , Aug 24, 2018 |  BioCentury  |  Finance

Navigating the Hot Topics landscape

Investors are making aggressive bets on the ability of early stage companies to deliver on the next generation of therapeutics and technologies. But advances in biology and novel technologies come with challenges ranging from unknown...
20:56 , Jul 2, 2018 |  BC Extra  |  Company News

Dunsire to become Lundbeck CEO

Neurology company H. Lundbeck A/S (CSE:LUN) hired Deborah Dunsire as president and CEO, effective Sept. 1. Dunsire will fill a position that became vacant when Kåre Schultz resigned in September 2017. CFO Anders Götzsche has...
12:03 , Mar 8, 2017 |  BC Extra  |  Company News

XTuit taps Dunsire as CEO

XTuit Pharmaceuticals Inc. (Waltham, Mass.) hired Deborah Dunsire as president and CEO. Dunsire was most recently president and CEO of Forum Pharmaceuticals Inc. , and is a former president and CEO of the Millennium Pharmaceuticals...
23:06 , Nov 3, 2016 |  BC Innovations  |  Targets & Mechanisms

Going against the gut

While patients might have a long wait for an HIV vaccine, several groups are working on the next best thing: strategies that boost patient immune systems to control the infection without the need for daily...
07:00 , Sep 7, 2016 |  BC Extra  |  Financial News

Financial tracks

Frazier Healthcare named Brock Hardaway as an operating partner on its growth buyout team. He was CEO at Millennium Health (San Diego, Calif.). Water Street Healthcare Partners named Nicklaus Daley VP. He was an associate...
00:30 , Jul 14, 2016 |  BC Extra  |  Company News

Decibel hires Holtzman as CEO

Hearing loss company Decibel Therapeutics Inc. (Cambridge, Mass.) named Steven Holtzman CEO. In March, Holtzman retired as EVP of corporate development at Biogen Inc. (NASDAQ:BIIB). He is the founder and former chairman and CEO of...
00:12 , Jul 6, 2016 |  BC Extra  |  Company News

EC expands Kyprolis label

Amgen Inc. (NASDAQ:AMGN) said the European Commission approved Kyprolis carfilzomib in combination with dexamethasone to treat multiple myeloma in adults who have received at least one prior therapy. The selective proteasome inhibitor previously was approved...